Recent Posts

News, partners
Congenica and IAB Agree to Distribution Deal in Central Europe
Posted 27th January 2022

Congenica and IAB Agree to Distribution Deal in Central Europe

Read More
News
Congenica launches Comprehensive Genetic Carrier Screening at Arab Health 2022 
Posted 24th January 2022

Congenica launches Comprehensive Genetic Carrier Screening at Arab Health 2022 

Read More
News
Congenica Expands its Clinical Consulting Services
Posted 13th January 2022

Congenica Expands its Clinical Consulting Services

Read More
News , RareDiseases , GenomicsEngland
Congenica named as genomic analysis platform in ‘Impact of the 100,000 Genomes Pilot – Preliminary Report’ in the New England Journal of Medicine
Posted 11th November 2021

Congenica named as genomic analysis platform in ‘Impact of the 100,000 Genomes Pilot – Preliminary Report’ in the New England Journal of Medicine

Read More
News , award
Congenica is Joint Winner of MIT Solve The Horizon Prize
Posted 20th September 2021

Congenica is Joint Winner of MIT Solve The Horizon Prize

Read More
News , Blog , RareDiseases
Congenica announced as a finalist for MIT Solve’s Horizon Prize
Posted 16th September 2021

Congenica announced as a finalist for MIT Solve’s Horizon Prize

Read More
News , Product , genomics , partners
Congenica signs distribution agreement with ATC Healthcare in Turkey
Posted 19th August 2021

Congenica signs distribution agreement with ATC Healthcare in Turkey

Read More
News , Investor , Product
Congenica Receives CE Mark for Genomic Analysis Software
Posted 21st July 2021

Congenica Receives CE Mark for Genomic Analysis Software

Read More
News , Blog , genomics
David Atkins welcomes the Government
Posted 7th July 2021

David Atkins welcomes the Government's Life Sciences Sector Vision

Read More
News , Investor
Clinical OMICs interview with David Atkins CEO Congenica
Posted 25th June 2021

Clinical OMICs interview with David Atkins CEO Congenica

Read More
News , Investor
Congenica funded to reduce fatal drug interactions by mapping genes
Posted 17th June 2021

Congenica funded to reduce fatal drug interactions by mapping genes

Read More
previous
1 2 3 4 5
... 11 next
News , partners
Congenica and IAB Agree to Distribution Deal in Central Europe
Posted 27th January 2022

Congenica and IAB Agree to Distribution Deal in Central Europe

Read More
News
Congenica launches Comprehensive Genetic Carrier Screening at Arab Health 2022 
Posted January Jan 24th 2022

Congenica launches Comprehensive Genetic Carrier Screening at Arab Health 2022 

Read More
News
Congenica Expands its Clinical Consulting Services
Posted January Jan 13th 2022

Congenica Expands its Clinical Consulting Services

Read More
News , RareDiseases , GenomicsEngland
Congenica named as genomic analysis platform in ‘Impact of the 100,000 Genomes Pilot – Preliminary Report’ in the New England Journal of Medicine
Posted November Nov 11th 2021

Congenica named as genomic analysis platform in ‘Impact of the 100,000 Genomes Pilot – Preliminary Report’ in the New England Journal of Medicine

Read More
News , award
Congenica is Joint Winner of MIT Solve The Horizon Prize
Posted September Sep 20th 2021

Congenica is Joint Winner of MIT Solve The Horizon Prize

Read More
News , Blog , RareDiseases
Congenica announced as a finalist for MIT Solve’s Horizon Prize
Posted September Sep 16th 2021

Congenica announced as a finalist for MIT Solve’s Horizon Prize

Read More
News , Product , genomics , partners
Congenica signs distribution agreement with ATC Healthcare in Turkey
Posted August Aug 19th 2021

Congenica signs distribution agreement with ATC Healthcare in Turkey

Read More
News , Investor , Product
Congenica Receives CE Mark for Genomic Analysis Software
Posted July Jul 21st 2021

Congenica Receives CE Mark for Genomic Analysis Software

Read More
News , Blog , genomics
David Atkins welcomes the Government
Posted July Jul 7th 2021

David Atkins welcomes the Government's Life Sciences Sector Vision

Read More
News , Investor
Clinical OMICs interview with David Atkins CEO Congenica
Posted June Jun 25th 2021

Clinical OMICs interview with David Atkins CEO Congenica

Read More
News , Investor
Congenica funded to reduce fatal drug interactions by mapping genes
Posted June Jun 17th 2021

Congenica funded to reduce fatal drug interactions by mapping genes

Read More
previous
1 2 3 4 5
... 11 next
CE 60px-Conformité_Européenne - WHITE27001 RGB Tick 60x60 Congenica UL® ISO 13485:2016 A28485 HIPAA Compliance

Copyright © 2022 Congenica Ltd. Company number: 8273616 Registered in England and Wales

Congenica is available as a CE Marked IVD clinical decision support platform for clinical diagnostic use for inherited genetic disorders in the UK and EU, Iceland, Lichtenstein, Norway, Switzerland and Turkey. In all other countries, ensuring compliance with relevant local, national and international clinical laboratory regulations is the responsibility of the laboratory.